---
ver: rpa2
title: Improving Clinical Decision Support through Interpretable Machine Learning
  and Error Handling in Electronic Health Records
arxiv_id: '2308.10781'
source_url: https://arxiv.org/abs/2308.10781
tags:
- uni00000048
- uni0000004c
- uni00000057
- uni00000044
- uni00000051
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: Trust-MAPS is a novel framework that translates clinical domain
  knowledge into high-dimensional mathematical constraints, projects EMR data onto
  these constraints to correct outliers, and generates trust-scores based on deviations
  from normal physiology. The framework improves machine learning model performance
  for clinical decision support tasks.
---

# Improving Clinical Decision Support through Interpretable Machine Learning and Error Handling in Electronic Health Records

## Quick Facts
- arXiv ID: 2308.10781
- Source URL: https://arxiv.org/abs/2308.10781
- Reference count: 40
- One-line primary result: Trust-MAPS framework improves sepsis prediction precision by 15% using interpretable trust-scores derived from physiological constraints

## Executive Summary
Trust-MAPS is a novel framework that translates clinical domain knowledge into high-dimensional mathematical constraints, projects EMR data onto these constraints to correct outliers, and generates trust-scores based on deviations from normal physiology. The framework improves machine learning model performance for clinical decision support tasks. In a sepsis prediction task using PhysioNet 2019 data, Trust-MAPS achieved an AUROC of 0.865 and precision of 0.922, a 15% improvement over baseline. Trust-scores emerged as clinically meaningful features that boost predictive performance and provide interpretability to ML models.

## Method Summary
Trust-MAPS works by first translating known physiological and biological constraints into mathematical inequalities, then using optimization to find the closest point within this feasible space to correct erroneous data. The framework then computes the distance from this corrected data to a set of constraints representing healthy/normal physiology, generating interpretable "trust-scores" that quantify deviation from the norm. These trust-scores are integrated as features into downstream machine learning pipelines, such as XGBoost models clustered by patient similarity, to improve sepsis prediction performance while providing clinically meaningful interpretability.

## Key Results
- Trust-MAPS achieved AUROC of 0.865 and precision of 0.922 on PhysioNet 2019 sepsis prediction task
- 15% improvement in precision compared to baseline models without Trust-MAPS projections
- Trust-scores emerged as some of the most important predictors for sepsis prediction across clusters

## Why This Works (Mechanism)

### Mechanism 1
- Claim: Trust-MAPS corrects EMR data by projecting it onto high-dimensional mathematical constraints that encode clinical domain knowledge, effectively removing outliers and errors.
- Mechanism: The framework translates known physiological and biological constraints into mathematical inequalities, then uses optimization to find the closest point within this feasible space. This "projection" step maps erroneous data back to a clinically valid range.
- Core assumption: The set of constraints accurately represents the true physical and physiological limits of the variables being modeled, and the optimization can find a valid projection.
- Evidence anchors:
  - [abstract] "Trust-MAPS, an algorithm that translates clinical domain knowledge into high-dimensional, mixed-integer programming models that capture physiological and biological constraints on clinical measurements. EMR data is projected onto this constrained space, effectively bringing outliers to fall within a physiologically feasible range."
  - [section 6.2.1] "We specify physical lower and upper bounds on each vital for each time period in the fixed six-hour time interval for each sub-patient, as well as constrain the rates of change of the clinical data per hour."
- Break condition: If the constraints are incomplete or incorrect, projections may not correct errors properly or could introduce new biases. If the optimization is computationally intractable for high-dimensional data, the method fails.

### Mechanism 2
- Claim: Trust-scores, calculated as the distance between corrected data and normal physiological constraints, provide a clinically meaningful measure of how sick a patient is and improve ML model performance.
- Mechanism: After correcting data via physical projection, Trust-MAPS projects this data onto a second set of constraints representing healthy/normal physiology. The Euclidean distance from this projection quantifies deviation from the norm, creating interpretable "trust-scores" that capture illness severity.
- Core assumption: The distance from normal physiological constraints correlates with clinical severity and provides predictive signal for downstream ML tasks.
- Evidence anchors:
  - [abstract] "We then compute the distance of each data point from the constrained space modeling healthy physiology to quantify deviation from the norm. These distances, termed 'trust-scores,' are integrated into the feature space for downstream ML applications."
  - [section 6.2.2] "We use these variable-wise distances to N as additional input features to our machine-learning models and observe that these normal distances or trust scores are some of the most important predictors for sepsis prediction."
- Break condition: If the normal constraints poorly represent healthy physiology or the distance metric doesn't capture relevant clinical information, trust-scores won't improve predictions. If the feature space becomes too high-dimensional, ML performance may degrade.

### Mechanism 3
- Claim: Using trust-scores as features in a clustered XGBoost model improves sepsis prediction precision and interpretability compared to baseline methods.
- Mechanism: The trust-scores are appended to the corrected EMR data, then SMOTE is used to address class imbalance. K-means clustering groups similar patients, and separate XGBoost models are trained per cluster, using trust-scores as highly important features for differentiating sepsis from non-sepsis cases.
- Core assumption: The augmented feature space with trust-scores provides discriminative power that baseline models without projections lack, and clustering improves model performance for heterogeneous patient data.
- Evidence anchors:
  - [abstract] "Trust-MAPS achieved an AUROC of 0.865 and precision of 0.922, a 15% improvement over baseline."
  - [section 6.3] "We validate the utility of Trust-MAPS by an ablation study in which we apply the same machine learning pipeline on the PhysioNet dataset, but without the Trust-MAPS projections-based processing, and compare the results."
- Break condition: If clustering doesn't capture meaningful patient subgroups, or if XGBoost overfits to trust-scores, performance gains may not materialize. If the precision-recall tradeoff shifts unfavorably, clinical utility diminishes.

## Foundational Learning

- Concept: Mixed-integer programming and constrained optimization
  - Why needed here: Trust-MAPS uses mixed-integer programs to solve the projection problems onto non-convex constraint sets that capture physiological relationships.
  - Quick check question: How would you formulate a projection onto a convex set vs a non-convex set with if-then-else constraints?

- Concept: Distance metrics and feature engineering in ML
  - Why needed here: Trust-scores are derived from Euclidean distances to constraint sets and are used as engineered features to improve model performance and interpretability.
  - Quick check question: Why might Euclidean distance be preferred over other metrics in this context, and what are the trade-offs?

- Concept: Class imbalance handling and SMOTE
  - Why needed here: The sepsis dataset is highly imbalanced, so SMOTE is used to synthesize minority class samples before clustering and model training.
  - Quick check question: What are the risks of using SMOTE in clinical data, and how might you validate that synthetic samples are realistic?

## Architecture Onboarding

- Component map: 
  - Data preprocessing: Imputation → Normalization → Log-transform → Sub-patient creation
  - Trust-MAPS projections: Physical projection (P) → Normal projection (N) → Trust-score generation
  - ML pipeline: SMOTE → K-means clustering → XGBoost per cluster → Thresholding for precision
  - Outputs: Sepsis predictions with interpretable trust-scores and feature importance

- Critical path: 
  - Impute missing values → Apply Trust-MAPS projections → Generate trust-scores → SMOTE resampling → Cluster → Train XGBoost → Threshold for precision

- Design tradeoffs:
  - Projection accuracy vs computational cost: Mixed-integer programs can be slow for large datasets
  - Fixed time windows vs. variable-length stays: Sub-patients standardize data but may lose temporal context
  - Cluster granularity vs. model complexity: More clusters can improve fit but increase training time

- Failure signatures:
  - Trust-scores are all near zero or max values: Constraints may be too loose/tight
  - Clusters have very uneven sepsis rates: Clustering isn't capturing meaningful subgroups
  - Precision drops but recall improves: Thresholding may be too conservative for clinical use

- First 3 experiments:
  1. Run Trust-MAPS projections on a small synthetic dataset with known outliers; verify projections correct values and trust-scores correlate with deviation from truth.
  2. Compare XGBoost performance with and without trust-scores on a held-out test set; confirm AUROC and precision improvements.
  3. Vary the number of clusters (e.g., 5, 10, 25) and observe impact on f-score and interpretability of feature importance.

## Open Questions the Paper Calls Out

### Open Question 1
- Question: How does the non-uniqueness of projections over non-convex constraint sets impact the robustness and interpretability of Trust-MAPS?
- Basis in paper: [explicit] The paper discusses that projections onto non-convex sets (like the physical and normal constraints) may have multiple solutions, as illustrated in Figure 1 (right). The authors mention that if non-uniqueness exists, it might indicate conflicting domain constraints that could be highlighted to clinicians for further arbitration.
- Why unresolved: The paper does not provide empirical evidence or theoretical analysis of how often non-uniqueness occurs in practice or how it affects the performance and interpretability of Trust-MAPS. The impact of non-uniqueness on the trust scores and subsequent machine learning predictions is not quantified.
- What evidence would resolve it: Empirical studies showing the frequency of non-unique projections in real clinical data, analysis of how different projection solutions affect trust scores and model predictions, and user studies with clinicians to assess the interpretability and utility of highlighting conflicting constraints.

### Open Question 2
- Question: What is the impact of alternative design choices for sepsis labeling, such as using a continuous sepsis score instead of a binary label?
- Basis in paper: [explicit] The paper mentions that when creating sub-patients, they set the sepsis label to '1' if the original patient developed sepsis in the time window considered for that sub-patient. They suggest that in future work, it would be interesting to consider setting the sepsis label as a continuous variable between 0-1 to show gradual progression to sepsis.
- Why unresolved: The paper does not explore the impact of using a continuous sepsis score on the performance and interpretability of Trust-MAPS. It is unclear how a continuous label would affect the projections, trust scores, and machine learning predictions.
- What evidence would resolve it: Comparative studies using both binary and continuous sepsis labels, analysis of how the choice of labeling scheme affects the distribution of trust scores, and evaluation of model performance and interpretability with continuous vs. binary labels.

### Open Question 3
- Question: How does the choice of distance metric (e.g., KL divergence) for calculating trust scores affect the performance and interpretability of Trust-MAPS?
- Basis in paper: [explicit] The paper mentions that they use Euclidean distance to calculate the distance of corrected data from the homeostasis constraints and refer to these distances as "trust-scores". They also state that in future work, they aim to investigate other distance metrics (e.g., KL divergence) for their projections pipelines.
- Why unresolved: The paper does not provide any empirical evidence or theoretical analysis of how alternative distance metrics would affect the trust scores, the projections, and the subsequent machine learning predictions. The choice of distance metric may impact the sensitivity of trust scores to different types of errors or deviations from normal physiology.
- What evidence would resolve it: Comparative studies using different distance metrics (e.g., Euclidean, KL divergence, Mahalanobis distance), analysis of how the choice of metric affects the distribution and interpretability of trust scores, and evaluation of model performance with different distance metrics.

## Limitations
- Exact formulations of the 9 physical constraints remain unspecified, making precise reproduction challenging
- Clustering assignment and per-cluster threshold tuning are not fully detailed, which could affect reported performance
- Reliance on mixed-integer programming for high-dimensional projections may limit scalability in real-world deployments

## Confidence
- **High Confidence**: The core mechanism of Trust-MAPS (projections onto physiological constraints, trust-score generation) is well-described and logically sound.
- **Medium Confidence**: The reported 15% performance improvement over baseline is plausible given the method's novelty, but exact replication would require full constraint definitions.
- **Low Confidence**: The clinical interpretability claims depend heavily on the specific constraint formulations and their physiological validity, which are not fully detailed.

## Next Checks
1. **Constraint Verification**: Implement the 9 physical constraints from section 6.2.1 and test projections on a synthetic dataset with known outliers to verify corrections and trust-score distributions.
2. **Model Ablation**: Train XGBoost with and without trust-scores on the PhysioNet dataset using patient-level train/test splits to confirm the reported AUROC and precision improvements.
3. **Interpretability Validation**: Examine feature importance rankings across clusters to verify that trust-scores consistently appear as top predictors and assess their clinical interpretability through consultation with domain experts.